The HOPA Annual Conference is the premier learning event for all practitioners who specialize in the field of hematology/oncology pharmacy. Conference programming is designed for seasoned and new practitioners alike, providing education and resources to help attendees deliver the highest quality of care for their patients. New at this year’s conference, HOPA will feature:
• Significant papers in hematology/oncology • An interdisciplinary practice panel focusing on the cost of cancer care• Practice management-focused general sessions• Chemotherapy safety sessions presented by the Institute for Safe Medication Practices• State of the Art in Oncology Pharmacy Research
Other conference highlights include eight hours of BCOP recertification credit, breakout sessions on topics including leadership and drug spending, and a variety of networking events. Three timely preconference sessions will be offered on March 16, allowing attendees to enrich their conference experience and maximize learning opportunities while in Atlanta.
Special Early Bird pricing ends February 5, 2016. For more information, visit www.hoparx.org.
HOPA
HOPA is a nonprofit professional organization formed in 2004 to help oncology and hematology pharmacy practitioners and their associates provide the best possible cancer care. HOPA supports research, conducts educational conferences to advance knowledge, encourages professional development and advocates for health policy issues that improve patient care. HOPA has more than 2,300 members and includes oncology pharmacists, as well as pharmacy interns, residents, technicians, researchers, and administrators specializing in hematology/oncology practice.